EN
Genome Editing and Epigenetic Modification Platform
Using CRISPR editing technology, we can edit and modify the DNA or RNA of human cells in vitro to enhance the superior function of the cells and reduce the adverse cellular reactions, which has a broad application prospect in the treatment of hereditary diseases, cancer therapy and regenerative medicine. The platform is a non-viral editing system, which is not only safer, but also able to achieve a stable editing efficiency of more than 90%.
